These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 23995195)
1. Sertraline and mirtazapine as geriatric antidepressants. Holland J; Bhogle M Psychiatr Danub; 2013 Sep; 25 Suppl 2():S286-90. PubMed ID: 23995195 [TBL] [Abstract][Full Text] [Related]
2. Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. Furukawa TA; Akechi T; Shimodera S; Yamada M; Miki K; Watanabe N; Inagaki M; Yonemoto N Trials; 2011 May; 12():116. PubMed ID: 21569309 [TBL] [Abstract][Full Text] [Related]
4. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Banerjee S; Hellier J; Dewey M; Romeo R; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Knapp M; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A Lancet; 2011 Jul; 378(9789):403-11. PubMed ID: 21764118 [TBL] [Abstract][Full Text] [Related]
5. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Romeo R; Knapp M; Hellier J; Dewey M; Ballard C; Baldwin R; Bentham P; Burns A; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Banerjee S Br J Psychiatry; 2013 Feb; 202():121-8. PubMed ID: 23258767 [TBL] [Abstract][Full Text] [Related]
7. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial. Zuidersma M; Chua KC; Hellier J; Voshaar RO; Banerjee S; Am J Geriatr Psychiatry; 2019 Sep; 27(9):920-931. PubMed ID: 31084994 [TBL] [Abstract][Full Text] [Related]
8. Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark. Ishtiak-Ahmed K; Christensen KS; Gasse C J Affect Disord; 2023 Aug; 334():21-25. PubMed ID: 37146907 [TBL] [Abstract][Full Text] [Related]
9. Tolerability and safety aspects of mirtazapine. Nutt DJ Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669 [TBL] [Abstract][Full Text] [Related]
11. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation. Licht RW; Qvitzau S Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594 [TBL] [Abstract][Full Text] [Related]
12. The effect of mirtazapine in patients with chronic pain and concomitant depression. Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597 [TBL] [Abstract][Full Text] [Related]
13. Mirtazapine: a newer antidepressant. Hartmann PM Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581 [TBL] [Abstract][Full Text] [Related]
14. Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients? Sun LM; Lin MC; Liang JA; Chang YJ; Chang SN; Sung FC; Muo CH; Kao CH Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1292-7. PubMed ID: 24115340 [TBL] [Abstract][Full Text] [Related]
15. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions. Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096 [TBL] [Abstract][Full Text] [Related]
17. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Nishtala PS; McLachlan AJ; Bell JS; Chen TF Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953 [TBL] [Abstract][Full Text] [Related]
18. New developments in the treatment of depression. Montgomery SA J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420 [TBL] [Abstract][Full Text] [Related]
19. Mirtazapine-induced hyponatremia in an elderly hospice patient. Ladino M; Guardiola VD; Paniagua M J Palliat Med; 2006 Apr; 9(2):258-60. PubMed ID: 16629552 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients. Nutt DJ Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]